In oncology-focused MedTech trials, imaging is the foundation for evaluating efficacy, ensuring device placement, and demonstrating clinical value. But how can you maintain consistent interpretation with high data volume, multicenter variability, and evolving criteria? Avania’s Core Lab.
This white paper explores how expert-driven imaging solutions from Avania’s Core Lab support oncology MedTech sponsors with centralized, standardized, and regulator-ready imaging analysis from first-in-human trials to pivotal studies. Download it now for insights into:
- Navigating the complexities of tumor response criteria across cancer types (RECIST, iRECIST, PCWG, mRECIST, RANO)
- Ensuring unbiased, consistent imaging reads with rigorous dual-review quality control processes
- Maintaining compliance with 21 CFR Part 11 and ISO 27001 standards for data integrity and security
- Accelerating timelines with real-time image access and transparent audit trails
- Enhancing regulatory readiness and trial success with centralized image analysis and expert criteria application
When reliable imaging data is critical to proving your device works, It Takes Avania.